[PDF][PDF] Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a …
TJM de Witte - 2004 - repository.ubn.ru.nl
BACKGROUND AND OBJECTIVES: Acute myeloid leukemia (AML) in the elderly is
associated with low rates of response to conventional chemotherapy and long-term survival …
associated with low rates of response to conventional chemotherapy and long-term survival …
[PDF][PDF] Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a …
S AMADORI, S SUCIU, R WILLEMZE… - …, 2004 - researchgate.net
Results. Among the 57 evaluable patients, 38 (67%) completed the entire sequential
treatment as planned. The overall response rate to the entire induction sequence was …
treatment as planned. The overall response rate to the entire induction sequence was …
[PDF][PDF] Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a …
S AMADORI, S SUCIU, R WILLEMZE… - …, 2004 - scholar.archive.org
Results. Among the 57 evaluable patients, 38 (67%) completed the entire sequential
treatment as planned. The overall response rate to the entire induction sequence was …
treatment as planned. The overall response rate to the entire induction sequence was …
Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II …
S Amadori, S Suciu, R Willemze, F Mandelli… - …, 2004 - pubmed.ncbi.nlm.nih.gov
Background and objectives Acute myeloid leukemia (AML) in the elderly is associated with
low rates of response to conventional chemotherapy and long-term survival, highlighting the …
low rates of response to conventional chemotherapy and long-term survival, highlighting the …
Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: A phase II …
S Amadori, S Suciu, R Willemze, F Mandelli… - …, 2004 - iris.uniroma1.it
Abstract Background and Objectives. Acute myelpid leukemia (AML) in the elderly is
associated with low rates of response to conventional chemotherapy and long-term survival …
associated with low rates of response to conventional chemotherapy and long-term survival …
Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II …
S Amadori, S Suciu, R Willemze, F Mandelli… - …, 2004 - haematologica.org
BACKGROUND AND OBJECTIVES: Acute myeloid leukemia (AML) in the elderly is
associated with low rates of response to conventional chemotherapy and long-term survival …
associated with low rates of response to conventional chemotherapy and long-term survival …
Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II …
S Amadori, S Suciu, R Willemze, F Mandelli… - …, 2004 - europepmc.org
Results Among the 57 evaluable patients, 38 (67%) completed the entire sequential
treatment as planned. The overall response rate to the entire induction sequence was …
treatment as planned. The overall response rate to the entire induction sequence was …
[引用][C] Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a …
S AMADORI, S SUCIU, P MUUS… - Haematologica …, 2004 - pascal-francis.inist.fr
Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as
first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) …
first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) …
[PDF][PDF] Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a …
S AMADORI, S SUCIU, R WILLEMZE, F MANDELLI… - …, 2004 - academia.edu
Results. Among the 57 evaluable patients, 38 (67%) completed the entire sequential
treatment as planned. The overall response rate to the entire induction sequence was …
treatment as planned. The overall response rate to the entire induction sequence was …
[PDF][PDF] Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a …
S AMADORI, S SUCIU, R WILLEMZE, F MANDELLI… - haematologica, 2004 - Citeseer
Results. Among the 57 evaluable patients, 38 (67%) completed the entire sequential
treatment as planned. The overall response rate to the entire induction sequence was …
treatment as planned. The overall response rate to the entire induction sequence was …